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Introduction
DNA replication and transcription are mediated by robust ma-
chineries that compete for the same regions of the genome 
during S phase of the cell cycle. Studies in yeast and mamma-
lian cells have shown that replication-transcription encounters 
are unavoidable and represent one of the major sources of DNA 
breakage and chromosomal rearrangements, particularly in cells 
subjected to replication stress (Azvolinsky et al., 2009; Barlow 
et al., 2013; Helmrich et al., 2013; Jones et al., 2013; Wilson 
et al., 2015). A correlation between replication stress–provoked 
genomic instability and active transcription is particularly ap-
parent in case of common fragile sites (CFSs) and recently 
identified early replicating fragile sites (ERFSs; Helmrich et al., 
2011; Barlow et al., 2013). CFSs are specific genomic regions 
that manifest as gaps or breaks on metaphase chromosomes, 
particularly when DNA replication is partially inhibited (Durkin 
and Glover, 2007). Interestingly, CFSs are frequently located 
within the coding region of very long genes whose transcrip-
tion takes even more than one cell cycle, making replication- 
transcription collisions inevitable (Helmrich et al., 2011). In 
contrast to late replicating CFSs, ERFSs are located within early 
replicating regions that contain clusters of highly transcribed 
genes (Barlow et al., 2013). ERFSs break spontaneously during 
replication, but their fragility is significantly increased by ex-
ogenously induced replication arrest in early S phase (Barlow 
et al., 2013). ERFS fragility is also dependent on the level of 
transcription activity at these loci, suggesting that it is driven by 
replication-transcription encounters (Barlow et al., 2013).
Despite accumulating evidence that conflicts between 
replication and transcription are frequent events in proliferat-
ing cells and have detrimental effects on genome integrity, lit-
tle is known about the molecular mechanisms underlying their 
resolution. In fission yeast, the progression of replication forks 
through actively transcribed genes depends on DNA helicase 
Pfh1, suggesting a general role for accessory helicases in the 
displacement of transcription complexes at sites of replica-
tion-transcription collisions (Sabouri et al., 2012). However, 
studies in budding yeast have shown that RNA-polymerase 
(RNAP) II mutants defective in transcription elongation impair 
replication fork progression and cause genomic instability, sug-
gesting that RNA PII transcription complex might actively par-
ticipate in the resolution of replication-transcription conflicts 
(Felipe-Abrio et al., 2015).
Collisions between replication and transcription machineries represent a significant source of genomic instability. RECQ5 
DNA helicase binds to RNA-polymerase (RNAP) II during transcription elongation and suppresses transcription- 
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Human RECQ5 belongs to the RecQ family of DNA he-
licases (Croteau et al., 2014). RECQ5 is known to associate 
with RNA PII during transcription elongation (Izumikawa et al., 
2008; Kanagaraj et al., 2010). It also localizes to DNA replica-
tion foci throughout S phase and interacts physically with the 
proliferating cell nuclear antigen (PCNA), a key component of 
the replisome (Kanagaraj et al., 2006). A recent study shows 
that RECQ5 controls the movement of RNA PII across genes 
to prevent it from pausing or arrest, a condition referred to as 
transcription stress (Saponaro et al., 2014). RECQ5 depletion 
results in transcription-dependent chromosome fragmentation 
during S phase and accumulation of chromosomal rearrange-
ments with the breakpoints located in genes and CFSs (Li et al., 
2011; Saponaro et al., 2014). Although the incidents of genome 
instability in RECQ5-depleted cells colocalize with the areas 
of elevated transcription stress (Saponaro et al., 2014), it is un-
clear whether RECQ5 operates directly at sites of interference 
between replication and transcription.
Here, we demonstrate that RECQ5 associates with tran-
scription complexes in DNA replication foci and counteracts 
replication fork stalling in RNA PI- and RNA PII-transcribed 
genes. We present evidence for a novel molecular mechanism 
involved in the resolution of replication-transcription collisions 
wherein RECQ5 promotes RAD18-dependent PCNA ubiq-
uitination by directly interacting with PCNA, and the helicase 
activity of RECQ5 promotes the processing of replication in-
termediates protected by BRCA1-dependent RAD51 filaments.
Results
RECQ5 associates with RNA PI 
transcription complexes
Previous studies have suggested that RECQ5 acts as an elon-
gation factor of the RNA PII transcription machinery (Sapon-
aro et al., 2014). To assess whether RECQ5 is also involved in 
RNA PI transcription, we tested by chromatin immunoprecipi-
tation (ChIP) whether RECQ5 associates with rDNA. Chroma-
tin prepared from asynchronously growing HEK293 cells was 
precipitated with antibodies against RECQ5 or the largest cat-
alytic subunit of RNA PI, RPA194. Immunoprecipitated DNA 
was subjected to quantitative real-time PCR (qPCR) analysis 
using primer pairs covering the entire rDNA repeat unit: (a) the 
promoter region (amplicon H42); (b) the transcription start site 
(TSS); (c) the pre-rRNA coding region (H0.4-H13); and (d) the 
intergenic spacer (IGS; H18 and H27; Fig. 1 A). We found that 
RECQ5 was significantly enriched on the pre-rRNA coding re-
gion, showing a distribution pattern similar to that of RPA194 
(Fig. 1 B). Moreover, inhibition of transcription by actinomycin 
D (ActD) resulted in the accumulation of RPA194 and RECQ5 
at the pre-rRNA TSS (Fig. 1 B).
To determine whether RECQ5 interacts with the compo-
nents of RNA PI transcription complex, a HEK293 cell extract 
was subjected to immunoprecipitation (IP) with anti-RECQ5 
antibody, and the immunoprecipitated material was tested for 
the presence of RPA194. To exclude RNA- or DNA-mediated 
interactions, the extract was treated with benzonase nuclease. 
We found that RPA194 coprecipitated with anti-RECQ5 anti-
body but not with control IgG, suggesting that RECQ5 forms 
a complex with RNA PI (Fig. 1 C). RECQ5-RNA PI interaction 
was confirmed by coimmunoprecipitation of RECQ5 with ecto-
pically expressed RPA43-GFP (Fig. S1 A).
To determine which region of RECQ5 is required for its 
interaction with RNA PI, different C-terminally truncated vari-
ants of GFP-tagged RECQ5 were overexpressed in HEK293 
cells and tested for RPA194 binding by IP (Fig. S1, B and C). 
The results showed that the interaction between RECQ5 and 
RPA194 was abolished by deletion of the last 61 C-terminal 
amino acids of the RECQ5 polypeptide (Fig. 1 D and Fig. S1, B 
and C). It should be noted that this RECQ5 variant (RECQ5ΔCt) 
also lacks a part of the Set2-Rpb1-interacting (SRI) domain, 
which binds to the hyperphosphorylated C-terminal repeat do-
main (CTD) of RNA PII and mediates the association of RECQ5 
with RNA PII-transcribed genes (Kanagaraj et al., 2010). Ac-
cordingly, RECQ5ΔCt showed reduced binding to the hyper-
phosphorylated form of RNA PII (IIo), whereas its binding to 
the hypophosphorylated form of RNA PII (IIa), mediated by 
the internal RNA PII–interacting (IRI) domain, was similar to 
that of wild-type RECQ5 (Kanagaraj et al., 2010; Fig.  1  D). 
Importantly, a RECQ5 variant lacking the IRI and SRI do-
mains (GFP-RECQ5ΔIRIΔSRI), which failed to bind RNA PII, 
still retained RPA194 binding activity (Fig.  1  D), suggesting 
that the RNA PI-interacting domain of RECQ5 is located ad-
jacent to the SRI domain.
Finally, by ChIP assay using anti-GFP antibody, we com-
pared the binding of ectopically expressed GFP-RECQ5 and 
GFP-RECQ5ΔCt to rDNA in HEK293 cells. The results showed 
that the C-terminal region of RECQ5 is required for the efficient 
binding of RECQ5 to the pre-rRNA coding region of the rDNA 
repeat unit (Fig.  1  E). Collectively, these results provide evi-
dence that RECQ5 binds to RNA PI during rDNA transcription.
RECQ5 depletion increases RNA PI density 
in the pre-rRNA coding region
To explore the possible involvement of RECQ5 in processes 
associated with RNA PI-directed transcription, we analyzed the 
effect of RECQ5 depletion on RPA194 density along rDNA re-
peat units in HEK293 cells. Interestingly, we observed a sig-
nificant enrichment of RNA PI in the pre-rRNA coding region, 
but not on the promoter, in cells lacking RECQ5 (Fig.  1  F). 
These cells did not show any alteration in the cell cycle pro-
file compared with mock-depleted cells (Fig. S1 D), excluding 
the possibility that the observed increase in RNA PI occupancy 
on rDNA was caused by an increase in the proportion of S/G2 
cells, where RNA PI-directed transcription reaches its highest 
level (Grummt, 2003). These data suggest that RECQ5 might 
counteract RNA PI transcription stalling.
RECQ5 depletion leads to amplification of 
DNA segments within the pre-rRNA coding 
region in cells exposed to replication stress
To determine whether RECQ5 is required for the stability of 
rDNA arrays, it was kept knocked down in HEK293 cells for 
12 d by successive siRNA transfections (Fig.  2  A). Subse-
quently, genomic DNA was isolated, and rDNA copy numbers 
at selected amplicons were measured by qPCR relative to Oct-4 
gene, which is not transcribed in HEK293 cells (Nejepinska 
et al., 2012). To assess whether RECQ5 prevents rDNA re-
combination arising as a consequence of interference between 
transcription and replication, cells were also exposed to mild 
replication stress generated by 0.2  mM hydroxyurea (HU; 
Fig. 2 A). We found that RECQ5 depletion caused DNA copy 
number variations, particularly within the pre-rRNA coding re-
gion of the rDNA repeat unit (Fig. 2 B). Importantly, upon HU 
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treatment, a significant amplification of DNA sequences within 
the pre-rRNA coding region was observed in RECQ5-depleted 
cells, but not in mock-depleted cells (Fig. 2 C). Such structural 
changes of rDNA likely arose as the consequence of DNA 
double-strand breaks generated within the pre-rRNA coding 
region by clashes between transcription and replication com-
plexes, suggesting an important role for RECQ5 in preventing 
rDNA instability arising from interference between replica-
tion and transcription.
Depletion of RECQ5 causes replisome 
stalling in actively transcribed genes
To explore the hypothesis that RECQ5 is involved in the reso-
lution of collisions between replication and transcription ma-
chineries, we investigated whether RECQ5 depletion leads to 
replication fork stalling at rDNA arrays. To this end, we mea-
sured DNA polymerase ε (Pol ε) occupancy along the rDNA re-
peat unit in mock- and RECQ5-depleted HEK293 cells released 
synchronously from a nocodazole (NC) block. The characteris-
tic feature of rDNA arrays is that the actively transcribed rDNA 
repeats are replicated in early S phase, whereas the silent repeats 
are replicated in late S phase (Li et al., 2005). Therefore, we first 
determined rDNA replication timing in our experimental setup. 
By IP of BrdU pulse-labeled DNA followed by PCR analysis, 
we found that the first wave of rDNA replication occurred 6–9 h 
after NC block release, whereas the late-replicating rDNA was 
detected 12–16  h after release (Fig.  3  A). Hence, mock- and 
RECQ5-depleted cells were cross-linked at 8 or 14  h after 
NC block release and subjected to ChIP assay using antibody 
against the catalytic subunit of Pol ε. We found that RECQ5 
depletion was associated with a significant enrichment of Pol 
ε on rDNA 8 h after NC block release (Fig. 3, B–D), when the 
replication of actively transcribed repeats occurred (Fig. 3 A). 
In contrast, the Pol ε occupancy profile at the late-replicating 
portion of rDNA (14 h after NC block release) was not affected 
by RECQ5 knockdown (Fig. 3 D). This suggests that RECQ5 
counteracts replication fork stalling in transcriptionally active 
rDNA repeats during early S phase.
We also examined the effect of RECQ5 depletion on rep-
lication fork progression through rDNA in cells exposed to mild 
replication stress. Mock- and RECQ5-depleted HEK293 cells 
were released from NC block in medium containing 0.2 mM HU, 
and the level of Pol ε binding to rDNA was analyzed 8 or 14 h after 
NC block release. As expected, HU treatment slowed down cell 
cycle progression, with cells being in early S phase at 14 h after 
release from the NC block (Fig. 3 B). Importantly, we observed 
that RECQ5 knockdown caused a gradual accumulation of Pol ε 
on the rDNA repeat unit over the analyzed time period (Fig. 3 E).
Finally, we investigated whether RECQ5 depletion led to 
replication fork stalling in RNA PII-transcribed genes. We used 
Figure 1. RECQ5 associates with RNA PI during transcription elongation. (A) Scheme of the human rDNA repeat unit showing location of the amplicons 
(in red) used in this study. ETS, external transcribed spacer; IGS, intergenic spacer. (B) Distribution of RECQ5 and RNA polymerase I (RPA194 subunit) 
along the rDNA repeat unit in nontreated or ActD-treated (1 µg/ml, 1 h) HEK293 cells determined by ChIP assay. (C) Coimmunoprecipitation of RPA194 
with RECQ5 from extracts of HEK293 cells. Where indicated, cell extract was treated with benzonase nuclease to degrade nucleic acids. (D) Interaction 
of RPA194 or RPB1 (the largest catalytic subunit of RNA PII) with wild-type and mutant forms of GFP-RECQ5 expressed ectopically in HEK293 cells. Cell 
extracts were subjected to IP with GFP-Trap_A beads. Bound proteins were analyzed by WB. The RECQ5 variants were visualized by Ponceau S staining. 
IIo, hyperphosphorylated form of RPB1; IIa, hypophosphorylated form of RPB1. (E) Binding of GFP-RECQ5 and GFP-RECQ5ΔCt to rDNA in HEK293 cells 
determined by ChIP assay using anti-GFP antibody. Expression of GFP-RECQ5 and GFP-RECQ5ΔCt was confirmed by WB (right). (F) RPA194 density along 
rDNA repeat unit in mock- or RECQ5-depleted HEK293 cells determined by ChIP assay. RECQ5 down-regulation (using siRECQ5 #1) was confirmed by 
WB (right). For B, E, and F, data are represented as mean ± SD.
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chromatin prepared from HEK293 cells exposed to 0.2 mM HU 
to analyze Pol ε occupancy on the coding regions of several 
constitutively transcribed genes. We chose the ACTG1 gene, 
which was previously shown to be occupied by RECQ5 in a 
RNA PII-dependent manner (Kanagaraj et al., 2010), and the 
genes encoding the ribosomal proteins RPS19 and RPL22. We 
found that RECQ5 depletion resulted in a significant enrich-
ment of Pol ε on the coding regions of all three genes at 14 h 
after NC block release (Fig.  3  F). Importantly, no significant 
enrichment of Pol ε was observed at amplicon ACTG1-I, which 
represents an intergenic region located ∼2 kb downstream of 
the ACTG1 transcription termination site (Fig.  3  F). Collec-
tively, these results suggest that RECQ5 counteracts replication 
fork stalling in actively transcribed genes, particularly under 
conditions of replication stress.
RECQ5 associates with transcription 
machinery in replication foci
RECQ5 was previously shown to accumulate in DNA replica-
tion foci (Kanagaraj et al., 2006). To identify the core complex 
bound by RECQ5 in these foci, we used the FRAP technique 
to measure the intranuclear mobility of GFP-tagged RECQ5 
before and after the blockage of transcription or replication. 
HEK293 cells were transfected with vectors expressing GFP-
tagged RECQ5 and RFP-tagged PCNA and brought to early S 
phase by the release from NC block. Live cell imaging revealed 
that GFP-RECQ5 formed discrete nuclear foci that largely 
colocalized with RFP-PCNA foci (Fig. 4 A, left). FRAP mea-
surements of GFP-RECQ5 in circular regions containing one to 
three replication foci showed a very high mobility of RECQ5, in 
both the replication foci and the surrounding area (Fig. 4, right). 
In contrast, PCNA is characterized by a very slow fluorescence 
recovery, on the order of minutes, indicating a stable association 
with replication forks (Sporbert et al., 2002; unpublished data). 
Thus, the observed fast fluorescence recovery of GFP-RECQ5 
in replication foci suggests that RECQ5 is not stably bound to 
the replication machinery. This was also supported by our ob-
servation that GFP-RECQ5 mobility in replication foci was not 
affected by aphidicolin (Aph), which inhibits DNA replication 
(Fig. 4). In contrast, inhibition of transcription by ActD dramat-
ically impaired the mobility of GFP-RECQ5 in replication foci 
(Fig.  4), whereas no change in the mobility of GFP-RECQ5 
outside the replication foci was observed (Fig.  4, magnified 
sections). These findings suggest that RECQ5 associates with 
transcription machinery in replication foci.
BRCA1 and RAD51 function at sites of 
replication-transcription interference
To gain insight into the role of RECQ5 in the resolution of 
conflicts between replication and transcription, we explored its 
functional relationship with proteins that are involved in the re-
pair of damaged replication forks. BRCA1, an important tumor 
suppressor, has been implicated in the stabilization and process-
ing of stalled replication forks, and it is known to be recruited 
to ERFSs both after HU-induced replication arrest and during 
normal replication (Schlacher et al., 2012; Barlow et al., 2013; 
Willis et al., 2014). BRCA1 forms discrete nuclear foci in un-
perturbed S-phase cells (Scully et al., 1997). Interestingly, we 
Figure 2. Ribosomal DNA instability in RECQ5-depleted 
cells. (A) Experimental scheme. RECQ5 was kept down- 
regulated in HEK293 cells for 12 d by successive transfec-
tions (T) of either siRECQ5#1 or esiRECQ5. Samples of cells 
were collected after each splitting (S) and analyzed by WB 
(bottom). Lamin B was used as loading control. Cells were 
treated with 0.2 mM HU at indicated time intervals (red lines) 
or left untreated. (B and C) Effect of RECQ5 depletion on 
rDNA stability in the absence or presence of 0.2 mM HU. 
The rDNA copy number at indicated amplicons (see Fig. 1 A) 
was measured by qPCR of genomic DNA (∼2 ng) relative to 
the Oct-4 gene. Data are represented as mean ± SD. *, P < 
0.0005; **, P < 0.00005 (two-tailed unpaired t test).
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found that the formation of BRCA1 foci in U2OS cells was 
impaired by cordycepin, which causes premature termination 
of transcription (Fig. 5, A and B; and Fig. S2 A), thus lowering 
the probability of replication-transcription clashes (Jones et al., 
2013). In contrast, the number of BRCA1 foci increased if cells 
were exposed to ActD, which is capable of arresting transcrip-
tion complexes on DNA, thereby creating a barrier to replication 
fork movement (Fig. 5, A–C; and Fig. S2 A). In agreement with 
this notion, RNA PI transcription complexes arrested on DNA 
by ActD treatment (Fig. 1 B) caused a significant increase in Pol 
ε occupancy on the rDNA repeat unit (Fig. S3 A). Neither of the 
transcription inhibitors used altered the percentage of S-phase 
cells (Fig. S2 B). Importantly, inhibition of DNA replication by 
Aph or HU significantly decreased the number of BRCA1 foci 
Figure 3. RECQ5 depletion leads to replication fork stalling in actively transcribed genes. (A) rDNA replication timing in HEK293 cells. Cells were released 
from NC block and pulse labeled with BrdU for 30 min before harvesting at the indicated time points. BrdU-labeled DNA was immunoprecipitated and 
analyzed by PCR using primer pair for amplicon H6. (B) Cell cycle distribution of HEK293 cells released from NC block for indicated periods of time in 
the presence or absence of 0.2 mM HU. (C) Western blot analysis of RECQ5 protein levels in chromatin (10 µg) used for ChIP assays. (D) DNA Pol ε 
occupancy on rDNA repeat unit in HEK293 cells transfected with either control siRNA (siControl) or RECQ5 siRNA (siRECQ5#1). Chromatin was isolated 
at indicated time points after the release from NC block and subjected to ChIP assay. (E) As in D, but cells were released from NC block into medium 
containing 0.2 mM HU. (F) Effect of RECQ5 knockdown on Pol ε occupancy on the indicated RNA PII-transcribed genes (RPS19, RPL22, and ACTG1). 
Chromatin for ChIP assay was prepared as in E. ATCG1-I represents a nontranscribed intergenic region located ∼2 kb downstream of ACTG1 stop codon. 
For D, E, and F, data are represented as mean ± SD.
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in both mock- and ActD-treated cells (Fig. 5 C and Fig. S2, C 
and D), suggesting that the formation of these foci is driven by 
interference between replication and transcription. To further 
characterize the nature of BRCA1 foci, we performed FRAP 
experiments to measure GFP-BRCA1 mobility in these sites be-
fore and after replication or transcription arrest. We found that 
BRCA1 mobility in cells treated with Aph (replication arrest) 
was similar to that measured in mock-treated cells (Figs. 5 D 
and S2 E). In contrast, BRCA1 mobility was dramatically re-
duced in cells treated with ActD (transcription arrest; Figs. 5 D 
and S2 E). These data suggest that BRCA1 localized in S-phase 
foci associates with the transcription machinery at sites of rep-
lication-transcription interference.
BRCA1 acts to form RAD51 filaments at arrested rep-
lication forks to protect them from nucleolytic degradation 
(Schlacher et al., 2012). Like BRCA1, RAD51 forms discrete 
nuclear foci in unperturbed S-phase cells, and the formation 
of these foci is strictly dependent on the presence of BRCA1 
(Scully et al., 1997; Fig. 5 E). Of note, RAD51 foci colocalize 
with BRCA1 foci only partially, suggesting that BRCA1 dis-
sociates from these sites upon RAD51 recruitment (Scully et 
al., 1997; Fig. S2 F). In agreement with the immobilization of 
BRCA1 upon ActD treatment, the formation of RAD51 foci in 
S-phase cells was strongly attenuated by ActD (Fig.  5  F and 
Fig. S2, C and G), which further confirmed that BRCA1 ac-
tivity is dependent on active transcription. RAD51 foci forma-
tion was also impaired in cells treated with the transcription 
terminator cordycepin or replication inhibitors HU and Aph 
(Fig. 5 F and Fig. S2, C and G). Combined treatment of cells 
with ActD and either HU or Aph further decreased the num-
ber of RAD51 foci per cell (Fig. 5 F and Fig. S2, C and G), 
suggesting that the formation of these foci is driven by replica-
tion-transcription interference.
Depletion of RECQ5 causes accumulation 
of unresolved replication intermediates
Next, we analyzed the frequency of BRCA1 foci in cells de-
pleted of RECQ5. Interestingly, RECQ5 depletion led to a re-
duction in the frequency of BRCA1 foci in unperturbed cells 
but not in ActD-treated cells (Fig. 5, A and B; and Fig. S2 A). 
These results suggest that RECQ5 is not required for BRCA1 
foci formation, but rather affects late steps of the process ini-
tiated by BRCA1 at sites of replication-transcription interfer-
ence. Thus, we investigated the effect of RECQ5 depletion on 
the frequency of RAD51 foci in S-phase cells. We found that 
in RECQ5-deficient cells, the number of RAD51 foci that did 
not colocalize with a BRCA1 focus was increased compared 
with RECQ5-proficient cells, whereas the number of colocaliz-
ing foci was not affected (Fig. 5 G). Interestingly, the RAD51 
inhibitor B02, which strongly inhibited RAD51 foci formation 
in mock-depleted cells, did not significantly reduce RAD51 
foci in RECQ5-depleted cells (Fig. 5 H). This suggests that in 
the absence of RECQ5, cells accumulate replication intermedi-
ates stabilized by RAD51.
Figure 4. RECQ5 associates with transcription complexes in replication foci. (A, left) GFP-RECQ5 foci selected for FRAP analysis colocalize with PCNA-RFP 
foci in mock-, aphidicolin-, and ActD-treated HEK293 cells. (right) Representative images from a FRAP sequence showing the fluorescence recovery of 
GFP-RECQ5 in replication foci under indicated conditions. Bleached regions are depicted in white circles and also separately magnified for ActD-treated 
cells. FRAP measurements of GFP-RECQ5 were performed 6–9 h after release of cells from NC block. (B) Graph showing mean ± SD (n = 8–12) of relative 
fluorescence recovery in the bleached regions as a function of time.
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To further explore this hypothesis, we monitored replica-
tion fork elongation in RECQ5-proficient and RECQ5-deficient 
cells by alkaline BrdU comet assay (Mórocz et al., 2013). In this 
assay, the stretches of newly synthesized DNA pulse labeled 
with BrdU are separated from the parental strand by alkaline de-
naturation and electrophoresis and are visualized as a comet tail 
by immunostaining with anti-BrdU antibody (Fig. 5 I). If DNA 
replication continues after BrdU pulse labeling, the nascent 
DNA strands become continuous and remain in the comet head 
(Fig. 5 I). In our experiments, we measured comet tail lengths 
at time points of 0, 2, and 4 h after the BrdU pulse. We found 
that at 4 h after BrdU labeling, RECQ5-depleted cells showed 
Figure 5. RECQ5 depletion leads to accumulation of unresolved replication intermediates at sites of replication-transcription interference. (A) Representa-
tive images of mock- and RECQ5-depleted (siRECQ5#2) U2OS cells stained for BRCA1 and EdU. Nuclei were stained with DAPI. EdU (20 µM) was added 
to cell cultures 1 h before fixation. Where indicated, cells were treated with cordycepin (50 µM) for 2 h or ActD (1 µg/ml) for 1 h before fixation. (B, left) 
Quantification of BRCA1 foci counts in EdU-positive nuclei of mock- or RECQ5-depleted U2OS cells represented in A. (right) Western blot analysis of U2OS 
cells transfected with indicated siRNAs. (C) Analysis of BRCA1 foci counts in EdU-positive nuclei of U2OS cells exposed to inhibitors of replication (5 µM 
Aph or 2 mM HU) for 90 min and/or transcription inhibitor (1 µg/ml ActD) for 1 h before fixation. Note that EdU was added 1 h before addition of Aph 
or HU. (D) Graph showing time dependency of relative fluorescence recovery for bleached nuclear regions containing GFP-BRCA1 foci in mock-, Aph-, and 
ActD-treated HEK293 cells. HEK293 cells were transfected with GFP-BRCA1 and PCNA-RFP (to identify cells in S phase) constructs, and FRAP measurements 
were performed 6–9 h after the release of cells from NC block. (E) Representative images of mock-, BRCA1-, RECQ5-, and BRCA1/RECQ5-depleted U2OS 
cells stained for RAD51 and EdU. Nuclei were stained with DAPI. (F) Analysis of RAD51 foci counts in EdU-positive nuclei of cells treated with 50 µM 
cordycepin for 2 h, or as in C. (G) Effect of RECQ5 depletion on the frequency of BRCA1-positive and BRCA1-negative RAD51 foci in U2OS cells. (H) 
Analysis of RAD51 foci counts in EdU-positive nuclei of RECQ5-proficient and RECQ5-deficient cells treated or not with the Rad51 inhibitor B02 (20 µM) 
for 6 h. (I) Representative images of mock- or RECQ5-depleted U2OS cells analyzed by alkaline BrdU comet assay. U2OS cells were pulse labeled with 
20 µM BrdU for 20 min and harvested at the indicated time points after the BrdU wash-off to perform alkaline comet assay followed by immunostaining 
of BrdU-labeled DNA and staining with SYBR Gold. (J and K) Statistical analysis of BrdU-positive comet tail lengths measured for mock-, RECQ5-, and 
BRCA1-depleted U2OS cells. Whiskers indicate 10th to 90th percentile. ns, not significant; *, P < 0.01; ***, P < 0.0001 (two-tailed unpaired t test). Data 
in B–D and F–H are represented as mean ± SD.
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substantially longer comet tails than mock-depleted cells, con-
firming that RECQ5 deficiency is associated with accumula-
tion of unresolved replication intermediates (Fig.  5, I and J). 
Similarly, BRCA1-depleted cells also displayed longer comet 
tail lengths compared with mock-depleted cells (Fig. 5 K). Im-
portantly, cells depleted for both RECQ5 and BRCA1 did not 
show a further increase in comet tail length as compared with 
cells depleted for either protein (Fig. 5 K). Collectively, the data 
described point to a coordinated action of RECQ5 and BRCA1/
RAD51 at sites of replication-transcription interference to pro-
mote replication fork recovery.
RECQ5 is required for RAD18-dependent 
PCNA ubiquitination at sites of replication-
transcription interference
Studies in budding yeast have shown that PCNA sliding clamp 
is unloaded from the lagging strand arm of stalled replication 
forks in a manner dependent on its ubiquitination at lysine 
164 (Yu et al., 2014). To explore the possible involvement of 
RECQ5 and BRCA1 in replisome remodeling during the res-
olution of conflicts between replication and transcription ma-
chineries, we examined effects of their depletion on the level of 
ubiquitinated PCNA (Ub-PCNA) in chromatin fraction of un-
perturbed HEK293 cells. Ub-PCNA was monitored by Western 
blotting (WB) as a form of PCNA with reduced electrophoretic 
mobility that is readily detected in chromatin fraction of cells 
exposed to HU (Fig. 6, A and B). Depletion of BRCA1, but not 
that of RECQ5, substantially increased the level of Ub-PCNA 
in chromatin (Fig. 6, A and B). This PCNA ubiquitination was 
largely alleviated by cordycepin, suggesting that it arises as a 
consequence of interference between replication and transcrip-
tion (Fig. 6, A and B). Importantly, almost no Ub-PCNA was 
detected in chromatin of cells depleted for both BRCA1 and 
RECQ5, suggesting that Ub-PCNA formation in the absence 
of BRCA1 depends on RECQ5 (Fig. 6, A and B). Moreover, 
depletion of RECQ5 alone increased the level of unmodified 
PCNA in chromatin, suggesting that RECQ5 might promote 
PCNA unloading (Fig. 6, A [low exposure] and C).
To explore this further, we measured the levels of Ub-
PCNA and unmodified PCNA in the chromatin fraction of 
HEK293 cells overexpressing GFP-RECQ5. We found that 
GFP-RECQ5 overexpression stimulated PCNA ubiquitination 
and reduced the levels of unmodified PCNA on chromatin in 
both mock-depleted and BRCA1-depleted cells (Fig. 6 D). A 
similar phenotype was seen upon replication arrest induced by 
HU (Fig. 6 A). Consistently, DNA synthesis in GFP-RECQ5–
overexpressing cells was strongly attenuated as revealed by 
measurement of EdU incorporation (Fig.  6  E). In contrast, 
overexpression of GFP-RECQ5 did not significantly affect 
transcription as measured by incorporation of 5-fluorouridine 
(Fig. 6 F). Interestingly, BRCA1-depleted cells overexpressing 
GFP-RECQ5 contained significantly higher levels of chroma-
tin-bound Ub-PCNA compared with BRCA1-proficient cells 
overexpressing GFP-RECQ5 or BRCA1-deficient cells ex-
pressing only GFP (Fig. 6 D). This suggests that in the absence 
of BRCA1, Ub-PCNA generated by a RECQ5-mediated mech-
anism accumulates on chromatin.
To confirm that RECQ5 promotes PCNA ubiquitination 
and unloading, we examined the effect of GFP-RECQ5 over-
expression on chromatin binding of a His-tagged version of a 
nonubiquitinable PCNA mutant, PCNA-K164R. We found that 
overexpression of GFP-RECQ5 did not affect the binding of 
PCNA-K164R to chromatin, whereas it significantly reduced 
chromatin binding of wild-type PCNA (Fig. 6 G, low exposure). 
As expected, binding of PCNA-K164R to chromatin was also 
not affected upon HU treatment (Fig. 6 G). Interestingly, over-
expression of a helicase/ATPase-dead mutant of RECQ5, GFP-
RECQ5-K58R (Garcia et al., 2004), dramatically increased the 
level of Ub-PCNA in chromatin without reducing the level of 
unmodified PCNA (Fig. 6 G), suggesting a role for the helicase 
activity of RECQ5 in PCNA unloading.
We also tested the effect of GFP-RECQ5 overexpression 
on the level of Ub-PCNA in chromatin of cells lacking RAD18, 
an E3 ubiquitin ligase, which is recruited to stalled replica-
tion forks to monoubiquitinate PCNA (Tsuji et al., 2008). We 
found that depletion of RAD18 impaired PCNA ubiquitina-
tion induced by the overexpression of wild-type GFP-RECQ5 
or GFP-RECQ5-K58R, suggesting that RECQ5 promotes 
RAD18-dependent PCNA ubiquitination (Fig. 6 H).
Next, we investigated a relationship between RECQ5 and 
RAD18 at the interface of replication and transcription. First, 
we characterized the nature of RAD18 foci in cells exposed to 
different transcription or replication inhibitors (Fig. S4). The 
formation of RAD18 foci in S-phase cells was decreased upon 
cordycepin treatment (Fig. 6 I), which prematurely terminates 
transcription. Cells exposed to HU or ActD treatment, condi-
tions leading to replication fork blockage, showed an increased 
number of RAD18 foci compared with untreated cells (Fig. 6 I). 
Importantly, combined treatment of cells with ActD and HU 
significantly decreased the number of RAD18 foci per cell 
(Fig. 6 I), suggesting that RAD18 foci formation is dependent 
on replication fork stalling caused by collisions with transcrip-
tion complexes. As in the case of RECQ5, RAD18 depletion 
increased the number of RAD51 foci in S-phase cells, and these 
foci also persisted after exposure of cells to B02 (Fig.  6  J). 
Moreover, codepletion of RAD18 and RECQ5 did not cause 
a further increase in the number of RAD51 foci in compari-
son with depletion of either protein (Fig. 6 J), suggesting that 
RAD18 and RECQ5 act in the same pathway to resolve rep-
lication intermediates. Importantly, RECQ5 depletion caused 
accumulation of RAD18 foci in S-phase cells, implying that 
RECQ5 is not involved in the recruitment of RAD18 to stalled 
forks (Fig.  6  K). Moreover, BRCA1 depletion, which causes 
replication stalling, did not significantly change the number of 
RAD18 foci in S-phase cells (Fig. 6 K), suggesting that the in-
creased frequency of RAD18 foci in RECQ5-deficient cells is 
a consequence of a defect in PCNA ubiquitination, leading to 
persistence of RAD18 at sites of stalled replication forks.
Helicase and PCNA-interacting domains 
of RECQ5 have distinct roles in the 
resolution of replication intermediates
Next, we wanted to identify the domains of RECQ5 involved 
in PCNA ubiquitination. For this, we prepared GFP-RECQ5 
variants containing the K58R mutation in the helicase domain 
(its overexpression caused accumulation of Ub-PCNA on chro-
matin; Fig. 6, G and H) in combination with either a R943A 
mutation in the SRI domain (abolishment of RECQ5 binding 
to RNA PII CTD) or mutations in the PCNA-interacting pep-
tide (PIP4A, abolishment of RECQ5–PCNA interaction). We 
tested the effect of overexpression of these RECQ5 variants 
on the level of chromatin-bound PCNA in HEK293 cells. We 
found that the K58R/PIP4A variant largely failed to induce 
PCNA ubiquitination, whereas K58R/R943A stimulated PCNA 
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Figure 6. RECQ5 promotes RAD18-dependent PCNA ubiquitination at sites of replication-transcription interference. (A) Western blot analysis of PCNA, 
RECQ5, BRCA1, and Lamin B2 (loading control) levels in chromatin fractions isolated from HEK293 cells transfected with indicated siRNAs. Where indicated, 
cells were treated with 2 mM HU for 14 h or 50 µM cordycepin (Cord.) for the last 2 h. NT, nontreated. For unmodified PCNA, high and low exposures are 
shown. (B and C) Quantitative analysis of band intensity of ubiquitinated PCNA (Ub-PCNA) and unmodified PCNA, respectively, on Western blots represented 
in A. PCNA intensity was normalized to Lamin B2 intensity. Data are expressed as percentage of Ub-PCNA levels in chromatin of HU-treated cells or as per-
centage of unmodified PCNA levels in chromatin of mock-depleted cells, respectively. n.d., signal was not detected. *, P < 0.01; **, P < 0.005 (two-tailed 
unpaired t test). (D) Western blot analysis of PCNA levels in chromatin fractions of mock- or BRCA1-depleted HEK293 cells transiently overexpressing either 
GFP or GFP-RECQ5. Lamin B2 was used as loading control. (E) Flow cytometry analysis of EdU incorporation (y axis) and DNA content (propidium iodide, 
x axis) in HEK293 cells performed 48 h after transfection of vectors expressing either GFP or GFP-RECQ5. Only GFP-positive cells were analyzed. (F) Flow 
cytometry analysis of 5-FU incorporation into nascent RNA in HEK293 cells expressing either GFP or GFP-RECQ5. Mock-treated HEK293 cells (without 5-FU) 
served as noise-signal control. (G) Western blot analysis of PCNA levels in chromatin fractions isolated from HEK293 cells transiently expressing wild-type (WT) 
or mutant (K164R) forms of His-tagged PCNA. Cells were treated with 2 mM HU for 14 h or transfected with vectors expressing either wild-type (GFP-Q5) or 
helicase/ATPase-dead mutant (GFP-Q5 K58R) of RECQ5. (H) Western blot analysis of PCNA levels in chromatin of HEK293 cells transiently overexpressing 
GFP, GFP-Q5, or GFP-Q5 K58R that were either mock- or RAD18-depleted. (I) Analysis of RAD18 foci counts in EdU-positive nuclei of U2OS cells exposed to 
transcription inhibitors cordycepin (Cord.; 50 µM for 2 h) and ActD (1 µg/ml for 1 h) and/or replication inhibitor (2 mM HU) for 90 min before fixation. Note 
that EdU was added 1 h before addition of HU or fixation. (J, left) Analysis of RAD51 foci counts in EdU-positive nuclei of mock-, RECQ5-, and/or RAD18- 
depleted cells treated or not with the Rad51 inhibitor B02 (20 µM) for 6 h. (right) Western blot analysis of U2OS cells transfected with indicated siRNAs. (K) 
Analysis of RAD18 foci counts in EdU-positive nuclei of U2OS cells transfected with indicated siRNAs. Data in B, C, and I–K are represented as mean ± SD.
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ubiquitination, although to a lesser extent compared with the 
K58R mutant (Fig.  7  A). These data suggest that RECQ5 
promotes PCNA ubiquitination by directly interacting with 
PCNA via the PIP motif.
To investigate the phenotypes of RECQ5 mutants if ex-
pressed at levels comparable to that of endogenous RECQ5 pro-
tein, we established a cellular system that uses a pAIO-based 
vector (Ghodgaonkar et al., 2014) for inducible replacement 
of the endogenous RECQ5 with an shRNA-resistant mutant of 
interest. We prepared stable U2OS T-REx cell lines inducibly 
expressing Flag-tagged versions of wild-type RECQ5, RECQ5-
K58R, RECQ5-R943A, and RECQ5-PIP4A, along with an 
shRNA targeting endogenous RECQ5. Thus, cells exposed to 
doxycycline (0.4 ng/ml) expressed a RECQ5 variant of inter-
est with concomitant down-regulation of endogenous RECQ5 
(Fig. S5). To detect Ub-PCNA in unchallenged cells, we used 
an antibody specifically recognizing ubiquityl-PCNA (Lys 
164). We found that the substitution of endogenous RECQ5 
with RECQ5-K58R caused accumulation of both Ub-PCNA 
and unmodified PCNA on chromatin (Fig.  7  B). Moreover, 
the lack of RECQ5 helicase activity increased the number of 
RAD51 foci in S-phase cells (Fig. 7 D). These results suggest 
that the helicase activity of RECQ5 prevents the accumulation 
of unresolved replication intermediates. On the contrary, the 
substitution of endogenous RECQ5 with RECQ5-PIP4A did 
not cause accumulation of unmodified PCNA nor Ub-PCNA on 
chromatin (Fig. 7 B). Instead, it increased the level of RAD18 
in chromatin fraction and the number of RAD18 foci in S-phase 
cells (Fig. 7, B and E), which is consistent with our earlier find-
ing of the requirement of RECQ5–PCNA interaction for PCNA 
ubiquitination. Interestingly, although the expression levels 
of all RECQ5 variants were comparable (Fig. 7 C), the levels 
of RECQ5-K58R and RECQ5-PIP4A in chromatin were sig-
nificantly increased compared with that of wild-type RECQ5 
(Fig.  7  B), providing a further evidence for a defect in their 
function. Together, these results suggest that a coordinated ac-
tion of the helicase and PCNA-interacting domains of RECQ5 
promotes the resolution of replication-transcription encounters.
Discussion
RECQ5 DNA helicase is essential for maintenance of genomic 
stability, but its exact molecular functions remain unclear. Re-
cent studies have shown that human RECQ5 binds to RNA PII 
during transcription elongation and maintains genomic stability 
at RNA PII-transcribed genes by acting as a factor that prevents 
transcription pausing or arrest, a condition termed transcription 
stress (Kanagaraj et al., 2010; Li et al., 2011; Saponaro et al., 
2014). Here, we show that RECQ5 also forms a complex with 
RNA PI during rDNA transcription, prevents RNA PI-transcrip-
tion stress, and enforces the stability of the pre-rRNA coding 
regions of rDNA arrays. These results are consistent with the 
proposal of RECQ5 acting as a general transcription elongation 
factor that is important for preserving genome stability during 
transcription (Kanagaraj et al., 2010; Li et al., 2011; Sapon-
aro et al., 2014). However, we also demonstrate that RECQ5 
depletion causes the persistence of unresolved replication in-
termediates with replisomes stalled in both RNA PI- and RNA 
PII-transcribed genes. These findings suggest that the genome 
stabilization effect of RECQ5 at sites of transcription might 
reflect a role for RECQ5 in resolving collisions between the 
replication and transcription machineries. In support of this 
hypothesis, we have found that RECQ5 associates with active 
Figure 7. Distinct roles of the helicase and PCNA-interacting domains of RECQ5 in resolution of replication intermediates. (A) Western blot analysis of 
PCNA levels in chromatin of HEK293 cells transiently overexpressing various mutants of GFP-RECQ5 with defects in the helicase activity (K58R), RNA 
PIIo binding (R943A), and PCNA-interacting motif (PIP4A). (B) Western blot analysis of chromatin fraction of U2OS T-REx cells with doxycycline-regulated 
expression of Flag-tagged (shRNA-resistant) wild-type RECQ5 (WT), RECQ5-K58R (K58R), RECQ5-R934A (R934A), or RECQ5-PIP4A (PIP4A). Endogenous 
RECQ5 in these cells is down-regulated by shRNA. Parental U2OS T-REx cells were transfected with siControl or siRECQ5. (C) Western blot analysis of 
whole cell extracts of U2OS T-REx cells in B. (D and E) Analysis of RAD51 or RAD18 foci counts in EdU-positive nuclei of U2OS T-REx cells as in B. Data 
in D and E are represented as mean ± SD.
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transcription complexes in DNA replication foci, suggesting 
that it acts at sites of concomitant replication and transcription. 
Moreover, our data show that BRCA1, RAD51, and RAD18, 
proteins involved in the stabilization and restart of stalled forks, 
form foci at sites of replication-transcription interference, where 
they cooperate with RECQ5 to resume replication. Finally, we 
provide evidence that RECQ5 promotes RAD18-dependent 
ubiquitination of PCNA by directly interacting with PCNA and 
that the helicase activity of RECQ5 promotes the resolution of 
replication intermediates stabilized by RAD51 filaments upon 
replication-transcription encounters.
Mechanisms that cells evolved to resolve conflicts be-
tween replication and transcription remain elusive. Studies in 
bacteria and yeast have shown that specific helicases act in 
conjunction with the replisome to disrupt transcription com-
plexes and other obstacles that impair replication fork progres-
sion (Azvolinsky et al., 2009; Boubakri et al., 2010; Sabouri et 
al., 2012). However, on very long genes in mammalian cells, 
collisions between transcription and replication complexes 
occur within each round of transcription, because the synthe-
sis of the full-length transcript of these genes takes more than 
one cell cycle (Helmrich et al., 2013). Therefore, to ensure 
proper gene expression, cells must have mechanisms that per-
mit RNA chain elongation after the collision with replication 
fork. Here, we provide evidence that RECQ5, BRCA1, and 
RAD18 are recruited independently of each other to sites of 
replication-transcription collisions. BRCA1-dependent load-
ing of RAD51 stabilizes the stalled replication forks for rep-
lication resumption (Schlacher et al., 2012). RECQ5 promotes 
RAD18-dependent PCNA ubiquitination and unloading from 
replication forks upon their collision with active transcription. 
It is therefore likely that RECQ5-mediated replisome remodel-
ing at stalled forks might allow the passage of oncoming tran-
scription complexes across the fork to complete RNA synthesis 
(Fig. 8 A). There is accumulating evidence suggesting a role for 
active transcription in the resolution of replication-transcription 
collisions. It was shown that RNA polymerase translocation is 
required for the resolution of head-on collisions between the 
transcription machinery and bacteriophage Φ29 DNA poly-
merase in Bacillus subtilis (Elías-Arnanz and Salas, 1999). 
Similarly, studies in budding yeast have shown that RNA PII 
mutants with a defect in transcription elongation impair repli-
cation fork progression and cause genomic instability (Felipe- 
Abrio et al., 2015). In addition, we have shown in human cells 
that halted RNA PI transcription complexes prevented the move-
ment of the replisome through rDNA (Fig. S3 A). Moreover, we 
provide evidence that replication forks stalled by halted tran-
scription complexes could be elongated once the RNA poly-
merase is allowed to resume transcription (Fig. S3 B). Thus, 
RNA polymerase might actively participate in the resolution of 
replication-transcription collisions.
Studies in budding yeast revealed the presence of a 
Fob1-dependent replication fork barrier at the 3′-end of the 
rDNA transcription unit that prevents head on clashes of the 
replisome with RNA PI transcription complexes (Takeuchi et 
al., 2003). However, termination of DNA replication throughout 
the rDNA transcription units has been observed in human cells, 
suggesting that replication fork barriers at the 3′ end of rDNA 
transcription units may not be absolute and that some leftward- 
moving forks pass through the barriers and enter the transcribed 
Figure 8. Model for resolution of conflicts between replication and transcription. (A) Scheme of the model. RECQ5, BRCA1, and RAD18 (R18) are 
recruited independently of each other to sites of replication-transcription collisions. BRCA1-dependent loading of RAD51 on stalled replication forks, 
which depends on active transcription, leads to fork stabilization. RECQ5 promotes RAD18-dependent PCNA ubiquitination and unloading at sites 
of replication-transcription interference that might allow the passage of oncoming transcription complexes across the fork to complete RNA synthesis. 
(B) Consequences of BRCA1 and RECQ5/RAD18 deficiencies. In the absence of BRCA1, RECQ5 can mediate PCNA ubiquitination and unloading, but 
the replication fork fails to restart because of the defect in RAD51 loading. In the absence of RECQ5 or RAD18, BRCA1 can promote assembly of RAD51 
filaments to protect stalled replication forks, but RNA polymerase cannot translocate across the replication fork, and hence replication restart is prevented. 
Failure of either of these activities would lead to persistence of stalled replication forks, resulting in genomic instability.
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region (Little et al., 1993). Such events would require a resolu-
tion mechanism like the one suggested by our study.
Our study provides evidence for a coordinated action of 
RECQ5 and BRCA1 at sites of replication-transcription colli-
sions, which leads to their resolution. We have found that cells 
lacking BRCA1 show increased levels of Ub-PCNA in chro-
matin, which is dependent on RECQ5 and transcription. On 
the other hand, cells lacking RECQ5 (as well as cells lacking 
RAD18) accumulate RAD51 nuclear foci that are formed in 
a BRCA1-dependent manner at sites of concomitant replica-
tion and transcription. These RAD51 foci in RECQ5-deficient 
cells likely represent unresolved replication intermediates 
because they display a long-term stability in the presence of 
RAD51 inhibitor B02, which prevents the formation of RAD51 
foci in normal cells. Our findings imply that in the absence of 
BRCA1, RECQ5 can mediate PCNA ubiquitination and un-
loading followed by RNA polymerase bypass, but the replica-
tion fork fails to restart because of the defect in RAD51 loading 
(Schlacher et al., 2012; Fig. 8 B). In the absence of RECQ5, 
BRCA1 can promote assembly of RAD51 filaments to protect 
stalled replication forks, but RNA polymerase cannot translo-
cate across the replication fork; hence replication restart is pre-
vented (Fig. 8 B). Thus, both the RECQ5-RAD18-PCNA and 
the BRCA1-RAD51 “arms” of this mechanism are required to 
properly resolve replication-transcription collisions. Failure of 
either of these activities would lead to the persistence of stalled 
replication forks, resulting in genomic instability (Fig. 8 B).
Studies in budding yeast have shown that strains defec-
tive in PCNA unloading (e.g., Δelg1 or PCNA-K164R mutants) 
exhibit uncontrolled DNA replication and accumulate Rad52 
foci, an indication of genomic instability (Yu et al., 2014). In-
terestingly, these studies have revealed that PCNA is unloaded 
only from the lagging strand arm of forks stalled by HU treat-
ment (Yu et al., 2014). In human cells, the process of replisome 
remodeling at stalled forks is not understood. We have shown 
that the PIP motif of RECQ5 induces RAD18-dependent ubiq-
uitination of PCNA, which accumulated on chromatin of cells 
expressing a helicase-dead mutant of RECQ5. Mutational in-
activation of the PIP motif of RECQ5 resulted in accumulation 
of RAD18 on chromatin in S-phase cells, indicating a failure 
in PCNA ubiquitination. However, PIP motif mutations did not 
apparently affect PCNA unloading induced by overexpression 
of GFP-RECQ5, which is also dependent on the modification 
of PCNA Lys-164 (Fig. 7 A, compare lanes 3 and 6). Of note, 
overexpression of GFP-RECQ5 led to the accumulation of Ub-
PCNA on chromatin, whereas unmodified PCNA was largely 
absent in chromatin under these conditions. A similar scenario 
can be observed for PCNA in HU-treated cells. Therefore, it 
is possible that the PIP motif of RECQ5 is involved in ubiq-
uitination of PCNA trimers that remain at stalled forks during 
the resolution of replication-transcription encounters. The un-
loaded PCNA is likely to be ubiquitinated independently of 
RECQ5’s PIP motif, but the unloading process depends on the 
helicase activity of RECQ5. This would explain our observation 
of increased Ub-PCNA levels in chromatin of RECQ5-depleted 
U2OS cells (Fig. 7 B, lane 5).
Interestingly, we have obtained evidence that BRCA1 as-
sociates with the transcription machinery at sites of replication- 
transcription interference. Moreover, we have found that ac-
tive transcription is required for the formation of BRCA1- 
dependent RAD51 foci in S-phase cells. Thus, BRCA1 might 
act in association with the transcription machinery during the 
process of resolution of replication-transcription collisions. 
Consistently, previous studies have shown that BRCA1 binds to 
hyperphosphorylated RNA PII present in the transcription elon-
gation complex (Krum et al., 2003).
Interference between replication and transcription rep-
resents a significant source of genome instability and contrib-
utes to oncogene-induced tumorigenesis (Poveda et al., 2010). 
Here, we provide evidence that RECQ5 exerts its genome 
maintenance function through its involvement in the resolu-
tion of collisions between replication and transcription com-
plexes. Because RECQ5 deficiency is associated with cancer 
susceptibility in mice (Hu et al., 2007), our study provides fur-
ther evidence for the role of replication-transcription interfer-
ence in cancer development.
Materials and methods
Antibodies, siRNAs, and plasmids
The following antibodies were used for WB, IP, ChIP, or immunoflu-
orescence staining (IF): rabbit polyclonal anti-RPA194 (WB, IP, and 
ChIP; sc-28714; Santa Cruz Biotechnology, Inc.), rabbit polyclonal 
anti-RECQ5 (WB, IP, ChIP, and IF; made in the laboratory), mouse 
monoclonal anti-GFP (WB and ChIP; ab290; Abcam), mouse mono-
clonal anti-Pol ε (ChIP; ab3163; Abcam), bridging antibody for mouse 
IgG (ChIP; 53017; Active Motif), mouse monoclonal anti–lamin B 
(WB; NA12; EMD Millipore), mouse monoclonal anti–lamin B2 (WB; 
gtx628803; GeneTex), rabbit polyclonal anti-TFI IH (WB; sc-293; 
Santa Cruz Biotechnology, Inc.), mouse monoclonal anti-PCNA (WB; 
sc-56; Santa Cruz Biotechnology, Inc.), mouse monoclonal anti-RNA 
PII (clone 7C2; WB; gift from J.-M.  Egly, Institute of Genetics and 
Molecular and Cellular Biology, Illkirch, France), mouse monoclo-
nal anti-BrdU (IF and IP; B2531; Sigma-Aldrich), mouse monoclonal 
anti-BRCA1 (WB; GTX70111; GeneTex), mouse monoclonal anti- 
BRCA1 (IF; sc-6954; Santa Cruz Biotechnology, Inc.), rabbit mono-
clonal anti-RAD18 (IF and WB; #9040; Cell Signaling Technology), 
rabbit monoclonal anti-ubiquityl-PCNA Lys164 (WB; #13439; Cell 
Signaling Technology), and mouse monoclonal anti-Flag (WB; F1804; 
Sigma-Aldrich). The siRNA oligonucleotides used in this study were 
purchased from Microsynth AG. The sequences of the sense strand of 
siRNA duplexes are 5′-CGU ACG CGG AAU ACU UCGA-3′ (siCon-
trol); 5′-GGA GAG UGC GAC CAU GGCU-3′ (siRECQ5#1); 5′-CAG 
GUU UGU CGC CCA UUG GAA-3′ (siRECQ5#2); and 5′-CAG GAA 
AUG GCU GAA CUA GAA-3′ (siBRCA1). The esiRECQ5 (MIS SION 
esiRNA human REC QL5; Sigma-Aldrich) and esiRAD18 (MIS SION 
esiRNA human RAD18; Sigma-Aldrich) are an siRNA pool. Transfec-
tions of siRNAs (10–40 nM) were done using Lipofectamine RNAi-
Max (Invitrogen) according to the manufacturer’s instructions. Cells 
were harvested 48–72 h after siRNA transfection. The EcoRV–KpnI 
fragment of the plasmid pJP136 containing human RECQ5 ORF 
was subcloned into the plasmid pAIO digested with EcoRV and KpnI 
(Schwendener et al., 2010; Ghodgaonkar et al., 2014). The resulting con-
struct was further modified as follows: (a) a DNA oligoduplex encoding 
for an shRNA corresponding to siRECQ5#1 (top strand: 5′-GAT CCC 
CGG AGA GTG CGA CCA TGG CTT TCA AGA GAA GCC ATG GTC GCA 
CTC TCC TTT TTG GAAA-3′; bottom strand: 5′-AGC TTT TCC AAA 
AAG GAG AGT GCG ACC ATG GCT TCT CTT GAA AGC CAT GGT CGC 
ACT CTC CGGG-3′) was introduced between the HindIII and BglII sites; 
(b) silent mutations were introduced into the RECQ5 cDNA between nu-
cleotides 102 and 120 to render the resulting RECQ5 transcript resistant 
to the shRNA; (c) the STOP codon in the RECQ5 cDNA was removed 
by site-directed mutagenesis to put the RECQ5 ORF in frame with the 
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3xFLAG tag present in the pAIO vector; (d) mutations were introduced 
into the RECQ5 ORF to generate K58R, R943A, PIP4A substitutions, 
respectively. Mutagenesis was performed using a QuickChange Site- 
Directed Mutagenesis kit (Agilent Technologies). The pEGFP-C1 deriv-
atives expressing GFP-tagged wild-type RECQ5, RECQ5ΔIRIΔSRI, or 
BRCA1 were described previously (Mailand et al., 2007; Kanagaraj et 
al., 2010). The previously mentioned point mutations were subcloned 
into GFP-RECQ5 construct. The truncated forms of GFP-RECQ5 cod-
ing for amino acids 1–930 (RECQ5ΔCt), 1–651, and 1–502 were cloned 
by PCR using Pfu DNA polymerase (Fermentas) and reverse primers 
5′-TCC TCG AGG CCC TCC TTG TAG AAA GGG GTG-3′, 5′-TCC TCG 
AGT TTG AGC GAG TAC ACA TGGG-3′, and 5′-GCA GGA TCC GCT 
TGT GGG CCT CAT CTC TG-3′, respectively. The resulting amplicons 
were digested with ScaI–XhoI (for 1–930 and 1–651) or ScaI–BamHI 
(for 1–502) and inserted between the ScaI–SalI or ScaI–BamHI sites in 
the GFP-RECQ5 plasmid. The PCNA-RFP and RPA43-GFP expression 
constructs were gifts from D. Stanek (Institute of Molecular Genetics, 
Prague, Czech Republic) and M. Dundr (Rosalind Franklin University 
of Medicine and Science, Chicago, IL), respectively. pcDNA3.1 deriv-
atives encoding for His-tagged wild-type PCNA or PCNA-K164R were 
described previously (Niimi et al., 2008). Plasmid transfections were 
performed using TransIT-2020 Reagent (Mirus Bio) according to the 
manufacturer’s instructions.
Cell culture
HEK293 and U2OS cells were cultured in DMEM (Sigma-Aldrich) 
supplemented with 10% FBS (Thermo Fisher Scientific) and strepto-
mycin/penicillin (100 U/ml). DMEM for cultivation of U2OS T-REx 
cells (Invitrogen) was supplemented with 10% Tet-system approved 
FBS (Biochrom). U2OS T-REx cells stably transfected with pAIO 
derivatives were selected in the presence of 1 µg/ml puromycin (In-
vivoGen). Doxycyclin (0.4 ng/ml) was added for 48 h to induce expres-
sion of recombinant RECQ5 proteins and down-regulate endogenous 
RECQ5. HEK293 cells were synchronized in mitosis by treatment 
with NC (0.1 µg/ml) for 14 h. Mitotic cells were shaken off, collected, 
washed twice with complete DMEM, and replated with fresh media. 
Where required, EdU was added to cell culture medium to a final 
concentration of 20 µM.
Flow cytometry
For analysis of cell cycle distribution by flow cytometry, cells were 
fixed with ethanol and stained with propidium iodide (PI; 10 µg/ml). 
EdU (20  µM, 1  h) or 5-FU (1  mM, 30 min) was added to medium 
before fixation with 4% paraformaldehyde in PBS, followed by per-
meabilization with 0.25% Triton X-100 in PBS for 5 min, EdU click 
reaction, or immunostaining with anti-BrdU antibody, respectively, 
and PI staining. Flow cytometry was performed using LSR II (BD) and 
FlowJo software (Tree Star).
Immunoprecipitation
For IP experiments, harvested cells were resuspended in lysis buffer 
(50 mM Tris-HCl, pH 7.5, 120 mM NaCl, and 0.5% Nonidet P-40) sup-
plemented with protease inhibitor cocktail (Roche) and incubated for 5 
min on ice. After sonication and subsequent centrifugation (16,000 g for 
10 min at 4°C), the supernatants (500 µg protein) were incubated at 4°C 
either for 1 h with 10 µl GFP-Trap_A beads (for GFP-tagged proteins; 
ChromoTek) or overnight with 2 µg primary antibody and ChIP-IT 
Protein G Magnetic Beads (Active Motif). Where indicated, mixtures 
were supplemented with 25 U Benzonase nuclease (EMD Millipore) 
and 5 mM MgCl2. Beads were washed three times in lysis buffer, and 
bound proteins were eluted by boiling with 2× Laemmli sample buffer.
Analysis of rDNA copy number
HEK293 cells were cultured on 6-cm dishes. The final concentration of 
siRNAs/esiRNA used for RECQ5 down-regulation was 40 nM at 0.4 
ng/µl for the first transfection and 20 nM at 0.2 ng/µl for subsequent 
transfections. HU (0.2 mM) was added after cell passage or at indi-
cated time points (Fig. 3 A). Samples for WB were collected during 
each passage. Genomic DNA was isolated using GenElute Mammalian 
Genomic DNA Miniprep kit (Sigma-Aldrich) according to the manu-
facturer’s instructions. Extracted DNA was diluted to a concentration 
of 2 ng/µl and subjected to qPCR performed on a LightCycler 480 PCR 
System using LightCycler 480 SYBR Green I Master Mix (Roche). 
The changes in rDNA copy number were calculated by the comparative 
ΔCp method (2-ΔΔCp) using Oct-4 gene for DNA amount normalization. 
The sequences of primers used for qPCR are shown in Table S1.
ChIP assays
ChIP assays were performed using the ChIP-IT Express kit (Active 
Motif) according to the manufacturer’s instructions. HEK293 cells 
were fixed with 1% formaldehyde for 10 min. Mock- or RECQ5- 
knockdown cells (asynchronous) were fixed 40 h after siRNA transfec-
tion. Cells released from NC block were fixed at indicated time points. 
NC was added 24 h after siRNA transfection to synchronize cells in 
mitosis, and treatment with 0.2 mM HU was started immediately after 
NC block release. HEK293 cells transfected with GFP-RECQ5 plas-
mids were fixed 24 h after transfection. Cross-linked chromatin was 
sheared by sonication (Diagenode Bioruptor, water-bath sonicator) to 
achieve DNA fragments of ∼300 bp. Fragmented chromatin contain-
ing ∼15 µg DNA was immunoprecipitated with 2 µg of specific an-
tibody or control IgG (or bridging antibody) overnight at 4°C. In the 
case of ChIP with anti-GFP antibody, reactions contained only ∼7 µg 
chromatin. After elution, cross-link reversal, and proteinase K diges-
tion of the immunoprecipitated chromatin, DNA was recovered using 
QIAquick PCR Purification kit (QIA GEN) and analyzed by qPCR. The 
sequences of primers used are shown in Table S1. The input chromatin 
was processed in the same way. DNA amounts were determined from a 
standard curve generated using input chromatin. Fold enrichment was 
calculated as a ratio of DNA amount precipitated by specific antibody 
versus DNA amount obtained with control IgG (or bridging antibody). 
Relative enrichment was calculated as the amount of precipitated DNA 
relative to the amount of DNA present in input chromatin (% of input), 
and normalized to the amplicon H27 of control sample.
Replication timing analysis
HEK293 cells were released from NC-induced mitotic arrest at indi-
cated time points and incubated with 30 µM BrdU for 30 min before 
harvesting. Genomic DNA was isolated by phenol/chloroform ex-
traction. 1 µg heat-denatured DNA was mixed with 5 µg anti-BrdU 
antibody and 15 µl ChIP-IT Protein G Magnetic Beads in 100 µl DNA 
binding buffer (50  mM Tris-HCl, pH 8, 120  mM NaCl, and 0.05% 
Triton X-100). After 1-h incubation, beads were washed with DNA 
binding buffer, and immunoprecipitated DNA was eluted by proteinase 
K treatment in the presence of 0.5% SDS. DNA was isolated using a 
QIAquick PCR Purification kit and subjected to PCR with primers am-
plifying the amplicon H6 (Fig. 1 B and Table S1). PCR products were 
analyzed by agarose electrophoresis.
Immunofluorescence microscopy and ScanR analysis
Cells grown on coverslips were fixed with 4% paraformaldehyde in 
PBS for 15 min and permeabilized with 0.25% Triton X-100 in PBS 
for 5 min. Coverslips were blocked with 1% BSA in PBS before in-
cubation with primary antibodies for 90 min. After washing in PBS, 
coverslips were incubated with appropriate Alexa Fluor–conjugated 
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secondary antibodies (Thermo Fisher Scientific) and mounted using 
Vectashield reagent (Vector Laboratories). Cell images were captured 
on a DM 6000 fluorescence microscope (Leica Biosystems) using an 
oil-immersion objective, 63×/1.4 NA. For RAD18 immunostaining, 
cells were preextracted with 25 mM Hepes-NaOH. pH 7.5, buffer con-
taining 50 mM NaCl, 1 mM EDTA, 3 mM MgCl2, 0.3 M sucrose, and 
0.5% Triton X-100 for 4 min at 4°C before fixation. In the case of 
BRCA1 and RAD51 immunostaining, methanol was used for perme-
abilization of cells (20 min at −20°C). EdU click reactions were per-
formed in buffer containing 100 mM Tris-HCl, pH 8.5, 2 mM CuSO4, 
100 mM ascorbate, and 5 µM Alexa Fluor 647 azide (Thermo Fisher 
Scientific) for 30 min in the dark followed by two washes with 1% BSA 
in PBS and immunostaining. DNA was counterstained with DAPI. For 
BRCA1, RAD51, and RAD18 foci counting and analysis, automated 
image acquisition was performed on an IX70 microscope (Olympus) 
equipped with ScanR imaging platform and 40×/1.3 NA oil-immersion 
objective. Nuclei were identified based on DAPI signal, and foci counts 
for each nuclear object were analyzed using a spot detection module of 
the Analysis ScanR software. At least 144 images were acquired and 
analyzed per sample (2,000 nuclei on average).
FRAP assays
FRAP measurements of GFP-RECQ5 and GFP-BRCA1 mobil-
ity in HEK293 cells were performed 6–9  h after the release from 
NC block. NC was added simultaneously with plasmid transfection 
(GFP-RECQ5/GFP-BRCA1 and PCNA-RFP), and cells were plated 
on glass-bottomed Petri dishes after NC removal. ActD (1 µg/ml) 
or Aph (10 µM) was added 30 min before the start of imaging. The 
cells were imaged with a SP5 confocal microscope equipped with an 
oil immersion objective (HCX Plan-Apochromat 63×/1.4 NA) and an 
environmental chamber controlling temperature (37°C) and CO2 level 
(5%). For GFP-RECQ5, data acquisition was performed using a 512 
× 512-pixel format at a 1,000-Hz scan speed and 1.6-Airy pinhole in 
8-bit resolution. After acquisition of eight prebleach images, a region 
of interest (circular spot 1.7 µm in diameter, covering one to three 
foci) was bleached with 100% laser power (488-nm line from an argon 
laser), and fluorescence recovery was monitored at low laser intensity 
in 110 iterations at 0.29-s intervals. For GFP-BRCA1, data acquisition 
was performed with modification in pixel format (1,024 × 1,024), and 
fluorescence recovery was monitored in 40 iterations at 4-s intervals. 
Fluorescence intensities of the bleached region and a proportionally 
equal distal unbleached area of the nucleus were measured at each time 
point using Fiji software. Values were corrected for extracellular back-
ground intensity and normalized to prebleach intensity to obtain rela-
tive fluorescence intensity.
Alkaline BrdU comet assay
Alkaline BrdU comet assay was performed as described previously 
(Mórocz et al., 2013). In brief, U2OS cells were pulse labeled with 20 µM 
BrdU for 20 min and chased in fresh medium for indicated periods of 
time. After washing in ice-cold PBS, 2 × 104 cells were resuspended in 
40 µl of 0.95% low-melting agarose (37°C; SeaPlaque GTG agarose; 
Lonza) dissolved in PBS, and the suspension was spread onto an agarose-
coated slide by covering with a coverslip. Agarose-embedded cells were 
lysed in ice-cold solution containing 10 mM Tris-HCl, pH 10, 2.5 M 
NaCl, 100 mM EDTA, 1% Triton X-100, and 0.5% N-lauroylsarcosine 
sodium salt for 90 min, with detergents added freshly before use, and 
washed three times for 5 min in PBS. The slides were placed in ice-cold 
alkaline electrophoresis solution (0.3 M NaOH and 1 mM EDTA, pH 
>13) for 40 min. Electrophoresis was subsequently conducted at 1 V/cm 
for 20 min in the same buffer. The slides were washed three times for 5 
min in neutralization buffer (0.4 mM Tris-HCl, pH 7.4) and twice for 
5 min in PBS and blocked with PBS-BT (PBS containing 0.1% Tween 
20 and 0.1% BSA) for 30 min before immunostaining. The slides were 
incubated with mouse monoclonal anti-BrdU antibody (B2531; Sigma-
Aldrich) for 1 h and washed three times with PBS and once with PBS-BT. 
Then the slides were incubated with secondary antibody Alexa Fluor 
647 and SYBR Gold (both Thermo Fisher Scientific) for 45 min. After 
three washes in PBS, slides were covered with coverslips and kept in a 
humidified box until microscopy. Comet images were captured on a DM 
6000 fluorescence microscope using a 20× objective, and the comet tail 
length was evaluated using OpenComet software (http ://www .cometbio 
.org). At least 50 cells were analyzed for each of at least three independent 
experiments. Statistical analysis was done using GraphPad Prism5.
Cell fractionation
To obtain chromatin fractions, cells were resuspended in buffer A 
(10 mM Hepes-NaOH, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M 
sucrose, 10% glycerol, and 1 mM DTT) supplemented with 1 mg/ml 
digitonin and incubated on ice for 5 min. Nuclei were collected by 
centrifugation at 1,500 g for 4 min, washed once with buffer A, resus-
pended in buffer B (3 mM EDTA, 0.2 mM EGTA, and 1 mM DTT), 
and incubated on ice for 15 min. Chromatin was separated from nucle-
oplasmic fraction by centrifugation at 2,000 g for 5 min and sheared by 
sonication in buffer B.
Online supplemental material
Fig. S1 shows interaction of ectopically expressed RECQ5 variants 
with RPA194. Fig. S2 shows frequencies of BRCA1 and RAD51 foci 
in nuclei of cells exposed to different replication and transcription 
inhibitors, and images from a FRAP sequence showing fluorescence 
recovery of GFP-BRCA1 foci in mock-, Aph-, and ActD-treated 
HEK293 cells. Fig. S3 shows occupancy of Pol ε on rDNA repeat units 
and analysis of BrdU comet tail lengths in nontreated and ActD-treated 
cells. Fig. S4 shows representative images of RAD18 foci in nuclei 
of cells exposed to different replication and transcription inhibitors. 
Fig. S5 shows relative mRNA abundance of endogenous and total 
RECQ5 in U2OS T-REx cells expressing RECQ5 variants. Table S1 lists 
the sequences of primers used for qPCR. Online supplemental material 
is available at http ://www .jcb .org /cgi /content /full /jcb .201507099 /DC1.
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